XTalks

APRIL 29, 2021

However, the variant viral genomes will still persist in the latent reservoir as provirus and can be detected with proviral DNA testing. In contrast to HIV RNA, HIV proviral DNA remains present in a patient’s cells even during virological suppression. Proviral DNA Genotyping. HIV Drug Resistance Testing.

DNA 98

DNA Drugs RNA Genotype 98

Drug Discovery World

FEBRUARY 28, 2024

Lu Rahman selects some of the year’s interesting and noteworthy advances in cancer research drug discovery and development. In the UK, according to Cancer Research UK, around 167,000 people die from cancer in the UK each year. Research into new drugs and therapeutics is on-going and is helping drive mortality rates down.

Development 62

Development Research Drugs Antibody 62

Drug Discovery World

SEPTEMBER 28, 2022

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists. . We’re proud to be a part of the journey of researchers and are eager to review submissions.” .

Genome 52

Genome Genomics Research Life Science 52

Drug Discovery World

APRIL 11, 2023

The molecule, known as lissodendoric acid A, appears to counteract other molecules that can damage DNA, RNA and proteins and even destroy whole cells. USP30 inhibition has been proposed as a therapeutic strategy for Parkinson’s disease.

Research 52

Research Drugs Life Science RNA 52

XTalks

JANUARY 26, 2024

Technological advancements are revolutionizing cancer research and therapies. This technology, which allows for precise editing of DNA at specific locations, has been a major focus in the field due to its potential to directly target and modify cancer-causing genes.

Research 118

Research Gene Editing Gene Genetics 118

Pharmaceutical Technology

FEBRUARY 16, 2023

These primarily include oxidative stress caused by the accumulation of reactive oxygen species, telomere shortening, and deoxyribonucleic acid (DNA)/histone methylation patterns. Telomeres are the buffer regions of DNA that cap the ends of chromosomes and prevent chromosomal attrition during DNA replication.

Insulin 130

Insulin DNA Genetics Life Science 130

Drug Discovery World

FEBRUARY 8, 2024

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. Why are those important?

Gene Therapy 57

Gene Therapy Gene Bioinformatics Life Science 57

Drug Discovery World

MAY 25, 2023

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. DDW provides an update. Torx Software: spring software release The spring release is designed to further enhance CRO management capabilities.

Production 52

Production Reagent DNA Drugs 52

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Drug Discovery World

OCTOBER 3, 2023

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy 52

Gene Therapy Gene Life Science Bioinformatics 52

Drug Discovery World

MARCH 29, 2023

In 2022, he was awarded a Commander of the Order of the British Empire (CBE) for services to UK Life Science. Within the last 15 years, she has undertaken senior positions predominantly within the healthcare and life sciences sectors, including Vice President for Talent at Astellas Pharma.

Life Science 52

Life Science DNA Business Development Drugs 52

Pharmaceutical Technology

MARCH 10, 2023

In the past, researchers have often had to seek help from outside the UK, thus delaying clinical trials and patient access. The opening of this new facility plays into the UK government’s Life Sciences Industrial Strategy. The NHSBT hopes the CBC will increase the UK’s competitiveness within the market.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

XTalks

MARCH 13, 2024

Related: Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments — Featuring Pierre Simon, VP Marketing, Sight Sciences – Xtalks Life Science Podcast Ep. Secondly, other funded research is exploring differential gene expression regulated by DNA methylation.

Gene Therapy 111

Gene Therapy Gene Life Science DNA 111

Drug Discovery World

MAY 5, 2023

Eterna Therapeutics, a life science company focused on mRNA cell engineering, has acquired Exacis Biotherapeutics’ immuno-oncology platform. In contrast to DNA-based reprogramming and gene editing, the mRNA-based approach does not expose cells to expensive and potentially harmful viruses or DNA vectors.

Gene Editing 52

Gene Editing Engineer DNA Life Science 52

pharmaphorum

OCTOBER 7, 2020

Originally discovered in bacteria as a defense mechanism against pathogens, CRISP/Cas9 has made it possible to make exquisitely detailed and precise alterations to DNA sequences on demand, and as a tool for molecular biology has already transformed research into diseases and drug discovery. What started as a curiosity?driven,

Gene Editing 105

Gene Editing Bacteria DNA Gene 105

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” About INOVIO’s DNA Medicines Platform. mg and 2.0

DNA 40

DNA Vaccination Vaccine Immune Response 40

Pharmaceutical Technology

MAY 15, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. Changzhou Fangyuan Pharmaceutical and Eisai stand in second and third positions, respectively.

Life Science 162

Life Science DNA Antibody Development 162

Drug Discovery World

JANUARY 30, 2023

DDW Editor Reece Armstrong takes a look at Lithuania’s life sciences sector and what it means for start-ups operating in the country. Despite consisting of largely small enterprises, Lithuania is still home to some large players in the life sciences sector including Thermo Fisher Scientific, Teva and Northway Biotech.

Life Science 98

Life Science Genome Genomics Development 98

Drug Discovery World

DECEMBER 14, 2023

The Federation of American Scientists (FAS) has published five policy recommendations to address the challenges of artificial intelligence (AI) in life sciences. FAS hopes that these recommendations will help inform policy development on these topics, including the work of the National Security Commission on Emerging Biotechnologies.

Scientist 52

Scientist DNA Life Science Development 52

pharmaphorum

JANUARY 30, 2022

2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. “History has handed the UK two world-leading sectors: life sciences and finance.

Life Science 98

Life Science Allergies DNA Licensing 98

XTalks

JULY 20, 2022

The production facility will be equipped to develop and manufacture plasmid DNA, nucleic acids, recombinant proteins and other therapeutics produced through methods involving microbial fermentation. Related: Biovectra to Build First mRNA Vaccine and Drug Manufacturing Plant in Canada. In addition to a $39.8

Vaccination 105

Vaccination Vaccine Manufacturing Life Science 105

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Genetics 130

Genetics DNA Genetic Engineering Antibody 130

XTalks

SEPTEMBER 30, 2020

While it remains unclear why some people become more gravely ill than others when infected with the SARS-CoV-2 virus that causes COVID-19, researchers have found that an immune deficiency may be part of it. The team sequenced DNA from 659 critically ill COVID-19 patients and 534 controls with mild or asymptomatic disease.

Antibody 135

Antibody Genetics Research In-Vitro 135

Drug Discovery World

OCTOBER 16, 2023

Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture.

Drugs 73

Drugs Life Science Gene Therapy Genome 73

Drug Discovery World

JULY 22, 2022

The centre was established in 2013 using funding from the UK Research & Innovation and has since provided synthetic biology start-ups and SMEs from across the UK with expertise, technical facilities, and business training. To date, the centre has helped 27 companies achieve a combined market capitalisation of £790 million. .

DNA 52

DNA Life Science Engineer Development 52

The Pharma Data

OCTOBER 19, 2020

Caris’ collaborative network focused on expanding the application of precision medicine in oncology supports Winship’s enterprising approach to research leading to transformative discoveries in cancer care and treatment. IRVING, Texas and ATLANTA , Oct. Winship is one of 32 U.S. Curran, Jr. , FACR, FASCO.

Life Science 52

Life Science Clinical Trials Clinical Trials RNA 52

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. While Toko Pharmaceutical Industrial and Catalent are in second and third positions, respectively.

Antibody 246

Antibody Vaccination Vaccine Dermatology 246

Drug Discovery World

OCTOBER 20, 2023

The acquisition of Olink underscores the profound impact that proteomics is having as our customers continue to advance life science research and precision medicine,” said Marc Casper, Chairman, President and Chief Executive Officer of Thermo Fisher.

Drugs 52

Drugs Antibody DNA Gene Therapy 52

XTalks

FEBRUARY 12, 2024

Taking viewers back to the scientific principles of Hippocrates to Sir Isaac Newton’s foundational work on gravity, Rosalind Franklin’s key role in the discovery of the structure of DNA to Pfizer scientist Kena Swanson’s work on the world’s first RSV vaccine Abrysvo for infants and older adults, the 60-second commercial takes viewers on a journey through (..)

Scientist 105

Scientist DNA Vaccination Vaccine 105

Drug Discovery World

JULY 11, 2023

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

Big Data 40

Big Data Development Life Science Drugs 40

The Pharma Data

APRIL 11, 2023

Bayer is progressing novel research around its prostate cancer treatment darolutamide. Both small molecule inhibitors in Immuno-Oncology are being jointly developed in a strategic research alliance with the German Cancer Research Center (DKFZ) in Heidelberg, Germany.

Research 40

Research Clinical Trials Clinical Trials Trials 40

XTalks

NOVEMBER 23, 2021

During the pandemic, the Government of Canada acknowledged recent shortcomings in the life sciences and biomanufacturing sectors. The funding is going towards vaccine research and development as well as construction of a manufacturing facility in Québec City.

Manufacturing 98

Manufacturing Vaccination Vaccine Drugs 98

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Protein 147

Protein Vaccination Vaccine Production 147

XTalks

SEPTEMBER 28, 2020

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). The test involves isolating circulating tumor DNA in the blood and sequencing it to look for relevant gene mutations.

Gene 105

Gene DNA Life Science Genotype 105

Drug Discovery World

FEBRUARY 13, 2023

What is important is how we use it, and SLAS2023 is taking the necessary next steps through a diverse range of talks and presentations, which ask: How has life sciences technology pushed innovation to boost the drug discovery process? How can technology help drug discovery research get to market faster and at optimum efficiency?

Genome 52

Genome Genomics Life Science Drugs 52

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. While eyeGene and Fundacion IrsiCaixa are in second and third positions, respectively.

Antibody 147

Antibody Vaccination Vaccine Dermatology 147